Our Company

CORPORATE RESPONSIBILITY

Accepting Challenges to Improve the Health of Humanity

Stemming from the core values of Alnylam, our approach to corporate responsibility embodies our “Challenge Accepted” philosophy. Our corporate responsibility mission statement—“Accepting challenges to improve the health of humanity”—helps articulate how we approach our work each day. It describes our commitment to tackling unprecedented and complex challenges, taking courageous action, and using our business as a force for good.

Go in depth—download our 2021 Corporate Responsibility Report to review details on Alnylam’s CR policies, practices and commitments. In addition to being included within the Report, SASB and GRI data tables can also be downloaded as a separate PDF.

Also check out our most recent Corporate Responsibility news or read Alnylam’s 2020 CR Summary

Four core beliefs guide our ongoing corporate responsibility work:

We believe in the noble pursuit of working to improve the health of humanity.
We believe science has the power to solve our many complex social, health, and environmental challenges.
We believe diverse, inclusive, and equitable environments are essential for achieving breakthroughs.
We believe all communities deserve access to health solutions and social support.

These beliefs inform our Corporate Responsibility as a company, and as advocates for five key areas of focus: patients, science, employees, communities, and our planet. Each of these has a guiding imperative, dedicated leadership team, and accountabilities to track and manage our impact.

Patients: We Strive to Improve Patients’ Lives and Enable Access to Potentially Life-Changing Treatments

At Alnylam, patients, their families and caregivers are at the forefront of everything we do. Alnylam teams throughout the world address issues related to disease education, diagnosis, treatment access, affordability, and equity. By actively listening to patients, their families, and caregivers, as well as healthcare providers and payers, we work to improve the patient journey every day.

Science: We Advocate for Science and Innovation to Address Critical Health and Social Issues

RNA interference (RNAi) has been a revolution in biology and has powered over 20 years of scientific pursuit that Alnylam moves forward each day. We believe that laboratory breakthroughs can be transformed into life-changing medicines for patients. We embrace our commitment to responsibly innovate, advance our science and pipeline, invest in R&D, collaborate across sectors, and advocate for science and the biopharmaceutical industry.

Employees: We Foster an Open, Diverse Culture Where Employees Feel Included, Supported, and Heard

Our business is powered by our employees, who are propelled by shared passion for innovation and desire to improve the lives of patients. We create opportunities for employees to expand their knowledge, grow their expertise, and incorporate diverse perspectives throughout their work.

Communities: We Actively Engage People in Tackling the World’s Most Pressing Community and Health Equity Challenges

Our patients, our employees and our business can only thrive when the communities surrounding us are resilient and sustainable. We prioritize addressing health inequities as a core focus of our community impact investments, and we actively seek to increase access to new medicines, improve the underlying social determinants of health that influence health outcomes, and help patients live healthier lives.

Alnylam Challengers – signature community impact program
Grants and Giving
Advocacy for Impact Grants
Independent Medical Education (IME) Grants
STEM and RNAi Education

Planet: We Seek to Improve the Health and Sustainability of Our Planet

As a biopharmaceutical company focused on improving the health of humanity, we have an important role to play in creating a more sustainable planet. Our teams continuously address energy use, greenhouse gas emissions, water use, waste, and other areas. We have taken meaningful steps to collect baseline data across our most important areas of focus in environmental management, have established tracking and measurement tools, and are working to determine targets that drive our environmental performance forward.

Corporate Responsibility Report

Go in-depth to learn more about our approach to corporate responsibility and specific actions we are taking as a company.

DOWNLOAD PDF

Governance: We Set High Standards for Our Employees and Partners

Our five-year business strategy, Alnylam P5x25, focuses on our transition to a top-five biotech by 2025. Investing in good governance is an essential business practice. We adhere to the highest level of ethical, compliance and legal standards and strive to apply a corporate responsibility (CR) lens toward business activities.